Abstract:BACKGROUND:At present, studies on MircoRNA-22-3p (miR-22-3p) in lung adenocarcinoma use a single method, lack multi-center validation and multi-method validation, and there is no big data concept to predict and validate target genes.OBJECTIVE:To investigate the expression, potential targets and clinicopathological significance of miR-22-3p in lung adenocarcinoma (LUAD) tissues.METHODS:LUAD formalin-fixed paraffin-embedded (FFPE) tumors and adjacent normal lung tissues were collected for real-time quantitative polymerase chain reaction (RT-qPCR). Collect miR-22-3p in LUAD and non-cancer lung tissue from high-throughput datasets, standardized mean difference (SMD) and area under the curve (AUC) of the comprehensive receiver operating curve (summary receiver operating characteristic cure, sROC curve) were calculated. Cell function experiments on A549 cells transfected with LV-hsa-miR-22-3p. Target genes were predicted by the miRwalk2.0 website and the resulting target genes were subjected to Gene Ontology (GO) pathway enrichment analysis and constructed to protein-protein interaction network. Finally, the protein expression level of the key gene TP53 was validated by searching The Human Protein Atlas (THPA) database to incorporate TP53 immunohistochemical results in LUAD.RESULTS:RT-qPCR result from 41 pairs of LUAD and adjacent lung tissues showed that miR-22-3p was downregulated in LUAD (AUC = 0.6597, p= 0.0128). Globally, a total of 838 LUADs and 494 non-cancerous lung tissues were included, and were finally combined into 14 platforms. Compared with noncancerous tissue, miR-22-3p expression level was significantly reduced in LUAD tissue (SMD =-0.32, AUC = 0.72l); cell function experiments showed that miR-22-3p has inhibitory effects on cell proliferation, migration and invasion, and has promotion effect on apoptosis. Moreover, target genes prediction, GO pathway enrichment analysis and PPI network exhibited TP53 as a key gene of target gene of miR-22-3p; at last, a total of 114 high-throughput datasets were included, including 3897 LUADs and 2993 non-cancerous lung tissues, and were finally combined into 37 platforms. Compared with noncancerous tissue, TP53 expression level was significantly increased in LUAD (SMD = 0.39, p< 0.01) and it was verified by the protein expression data from THPA.CONCLUSION:Overexpression of miR-22-3p may inhibit LUAD cell proliferation, migration and invasion through TP53, and promote cell apoptosis.

MicroRNA-147b Promotes Lung Adenocarcinoma Cell Aggressiveness Through Negatively Regulating Microfibril-Associated Glycoprotein 4 (MFAP4) and Affects Prognosis of Lung Adenocarcinoma Patients.

Identification of Stage-associated MicroRNAs in Lung Adenocarcinoma Based on Microarray Data

The Upregulation of TMPRSS4, Partly Ascribed to the Downregulation of Mir‑125a‑5p, Promotes the Growth of Human Lung Adenocarcinoma Via the NF‑κB Signaling Pathway

MicroRNA Expression Profiles Predict Progression and Clinical Outcome in Lung Adenocarcinoma

Downregulated MFAP4 expression is correlated with macrophage polarization and indicates poor prognosis in lung adenocarcinoma

Comprehensive Analysis of Aberrantly Expressed Microrna Profiles Reveals Potential Biomarkers of Human Lung Adenocarcinoma Progression.

MiR-1976/NCAPH/P65 axis inhibits the malignant phenotypes of lung adenocarcinoma

Downregulation of hsa-miR-30b-3p Inhibits the Oncogenicity of Lung Adenocarcinoma by Targeting the METTL7B Gene

MiR-937-3p Promotes Metastasis and Angiogenesis and is Activated by MYC in Lung Adenocarcinoma

Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9

Mir-186-5p Promotes Cell Growth, Migration and Invasion of Lung Adenocarcinoma by Targeting PTEN

MiR-629-5p Promotes the Invasion of Lung Adenocarcinoma Via Increasing Both Tumor Cell Invasion and Endothelial Cell Permeability

Negatively Regulated by miR-29c-3p, MTFR1 Promotes the Progression and Glycolysis in Lung Adenocarcinoma via the AMPK/mTOR Signalling Pathway

miR-210-3p Promotes Lung Cancer Development and Progression by Modulating USF1 and PCGF3

The Clinical Significance and Mechanism of Microrna-22-3p Targeting TP53 in Lung Adenocarcinoma.

LINC00968 Can Inhibit the Progression of Lung Adenocarcinoma Through the Mir-21-5p/smad7 Signal Axis.

MiR-579 Inhibits Lung Adenocarcinoma Cell Proliferation and Metastasis via Binding to CRABP2

Mir-550A-5p Functions As a Tumor Promoter by Targeting LIMD1 in Lung Adenocarcinoma

LncRNA-AC009948.5 Promotes Invasion and Metastasis of Lung Adenocarcinoma by Binding to Mir-186-5p

Clinical Value of Microrna-198-5p Downregulation in Lung Adenocarcinoma and Its Potential Pathways.

The Mir-4732-5p/xpr1 Axis Suppresses the Invasion, Metastasis, and Epithelial–mesenchymal Transition of Lung Adenocarcinoma Via the PI3K/Akt/GSK3β/Snail Pathway